Post-Implantation Tensioning in Cardiac Implants

Abstract

A method of treating a heart of a patient is provided. The method includes implanting a first tissue anchor in cardiac tissue of the patient and a second tissue anchor in the patient, such that the first and the second tissue anchors are coupled together by one or more tethers. Thereafter, after allowing at least 24 hours for tissue growth on the first tissue anchor to strengthen anchoring of the first tissue anchor in the cardiac tissue, tension is applied between the first and the second tissue anchors using at least a longitudinal portion of the one or more tethers. Other embodiments are also described.

Claims

1. A method of treating a heart of a patient, comprising: implanting a first tissue anchor in cardiac tissue of the patient and a second tissue anchor in the patient, such that the first and the second tissue anchors are coupled together by one or more tethers; thereafter, after allowing at least 24 hours for tissue growth on the first tissue anchor to strengthen anchoring of the first tissue anchor in the cardiac tissue, applying tension between the first and the second tissue anchors using at least a longitudinal portion of the one or more tethers.

2. The method according to claim 1, wherein the one or more tethers are slack before applying the tension.

3. The method according to claim 1, wherein the one or more tethers are one or more first tethers, and wherein applying the tension comprises: coupling a second tether to a coupling site along the one or more first tethers; and applying the tension between the first and the second tissue anchors using the at least a longitudinal portion of the one or more first tethers and the second tether.

4. The method according to claim 3, wherein coupling the second tether to the coupling site comprises coupling, to the coupling site, a coupling element that is attached to the second tether.

5. The method according to claim 4, wherein the coupling element comprises a hook.

6. The method according to claim 3, wherein applying the tension comprises coupling the second tether to the second tissue anchor.

7. The method according to claim 6, wherein the second tissue anchor comprises a stent that comprises a plurality of struts, and wherein coupling the second tether to the second tissue anchor comprises coupling, to one or more of the struts, a coupling element that is attached to the second tether.

8. The method according to claim 7, wherein the coupling element comprises a hook.

9. The method according to claim 7, wherein the coupling element is shaped so as to define an opening.

10. The method according to claim 7, wherein at least one of the struts is oriented axially as a backbone, and wherein coupling the coupling element to the one or more of the struts comprises coupling the coupling element to the backbone.

11. The method according to claim 10, wherein the backbone is shaped so as to define one or more hooks, and wherein coupling the coupling element to the backbone comprises coupling the coupling element to one or more of the hooks.

12. The method according to claim 1, wherein a longitudinal portion of the one or more tethers passes through one or more openings of a locking frame so as to form a tether loop, and wherein applying the tension comprises enlarging the tether loop by pulling on the tether loop.

13. The method according to claim 12, wherein the one or more openings are two openings, and wherein the longitudinal portion of the one or more tethers passes through the two openings.

14. The method according to claim 1, wherein applying the tension comprises applying the tension after allowing at least one week for tissue growth on the first tissue anchor.

15. The method according to claim 1, wherein applying the tension comprises applying the tension within two months after implanting the first tissue anchor.

16. The method according to claim 1, wherein implanting the first tissue anchor comprises implanting the first tissue anchor in the vicinity of the tricuspid valve of the patient.

17. The method according to claim 1, wherein implanting the second tissue anchor comprises implanting the second tissue anchor in a blood vessel selected from the group consisting of: a superior vena cava (SVC), an inferior vena cava (IVC), and a coronary sinus.

18. A method of treating a heart of a patient, comprising: implanting a first tissue anchor in cardiac tissue of the patient; thereafter, after allowing at least 24 hours for tissue growth on the first tissue anchor to strengthen anchoring of the first tissue anchor in the cardiac tissue: implanting a second tissue anchor in the patient; coupling the first and the second tissue anchors together using one or more tethers; and applying tension between the first and the second tissue anchors using the one or more tethers.

19. The method according to claim 18, wherein coupling the first and the second tissue anchors together comprises coupling the first and the second tissue anchors together after implanting the second tissue anchor.

20. The method according to claim 18, wherein coupling the first and the second tissue anchors together comprises coupling the first and the second tissue anchors together before implanting the second tissue anchor.

21. The method according to claim 18, wherein the one or more tethers are one or more first tethers, wherein the method further comprises implanting a third tissue anchor in cardiac tissue of the patient, such that the first and the third tissue anchors are coupled together by one or more second tethers, wherein coupling the first and the second tissue anchors together comprises coupling the first, the second, and the third tissue anchors together using the one or more first tethers and the one or more second tethers, and wherein applying the tension between the first and the second tissue anchors comprises applying the tension between the first, the second, and the third tissue anchors using the one or more first tethers and the one or more second tethers.

22. The method according to claim 21, wherein implanting the third tissue anchor comprises implanting the third tissue anchor within three hours of implanting the first tissue anchor.

23. The method according to claim 21, wherein the one or more first tethers are attached to the second tissue anchor and comprise a coupling element, and wherein coupling the first, the second, and the third tissue anchors together using the one or more first tethers and the one or more second tethers comprises coupling the coupling element to the one or more second tethers.

24. The method according to claim 23, wherein the coupling element comprises a hook, and wherein coupling the coupling element to the one or more second tethers comprises hooking the hook onto the one or more second tethers.

25. The method according to claim 18, wherein the first tissue anchor comprises a tissue-anchoring element and a first coupling element, wherein the one or more tethers are attached to the second tissue anchor and comprise a second coupling element, and wherein coupling the first and the second tissue anchors together using the one or more tethers comprises coupling the second coupling element to the first coupling element.

26. The method according to claim 25, wherein the first coupling element comprises a ball, wherein the second coupling element comprises a socket, and wherein coupling the first and the second tissue anchors together comprises coupling the socket to the ball.

27. The method according to claim 26, wherein the ball is connected to a head of the first tissue anchor by a rod.

28. The method according to claim 26, wherein coupling the socket to the ball comprises transitioning the socket from an open, unlocked state to a closed, locked state around the ball.

29. The method according to claim 25, wherein the first coupling element comprises a socket, wherein the second coupling element comprises a ball, and wherein coupling the first and the second tissue anchors together comprises coupling the ball to the socket.

30. The method according to claim 25, wherein the first coupling element comprises a loop, wherein the second coupling element comprises a hook, and wherein coupling the first and the second tissue anchors together comprises hooking the hook onto the loop.

31. The method according to claim 25, wherein the second coupling element comprises a loop, and wherein coupling the first and the second tissue anchors together comprises coupling the loop to the first coupling element.

32. The method according to claim 31, wherein the first coupling element comprises a hook, and wherein coupling the loop to the first coupling element comprises coupling the loop to the hook.

33. The method according to claim 25, wherein the first coupling element is coated with a tissue-growth-inhibiting coating.

34. The method according to claim 25, wherein the tissue-anchoring element is coated with a tissue-growth-enhancing coating.

35. The method according to claim 18, wherein implanting the second tissue anchor comprises implanting the second tissue anchor after allowing at least one week for tissue growth on the first anchor.

36. The method according to claim 18, wherein implanting the second tissue anchor comprises implanting the second tissue anchor within two months after implanting the first tissue anchor.

37. The method according to claim 18, wherein the first tissue anchor comprises a helical tissue-anchoring element.

38. The method according to claim 18, wherein the second tissue anchor comprises a stent.

39. The method according to claim 18, wherein implanting the second tissue anchor comprises implanting the second tissue anchor in a blood vessel selected from the group consisting of: a superior vena cava (SVC), an inferior vena cava (IVC), and a coronary sinus.

40. The method according to claim 18, wherein implanting the first tissue anchor comprises implanting the first tissue anchor in the vicinity of the tricuspid valve.

41. The method according to claim 40, wherein applying the tension between the first and the second tissue anchors using the one or more tethers reduces tricuspid valve regurgitation.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0116] FIGS. 1A-E are schematic illustrations of a technique of treating a heart of a patient, in accordance with an application of the present invention;

[0117] FIGS. 2A-D are schematic illustrations of another technique for treating a heart of a patient, in accordance with an application of the present invention;

[0118] FIGS. 3A-D are schematic illustrations of coupling elements, in accordance with respective applications of the present invention;

[0119] FIGS. 4A-D are schematic illustrations of a technique for treating a heart of a patient, in accordance with respective applications of the present invention;

[0120] FIGS. 5A-D are schematic illustrations of another technique for treating a heart of a patient, in accordance with respective applications of the present invention;

[0121] FIGS. 6A-B are schematic illustrations of a yet another technique for treating a heart of a patient, in accordance with respective applications of the present invention;

[0122] FIGS. 7A-D are schematic illustrations of a further technique for treating a heart of a patient, in accordance with respective applications of the present invention;

[0123] FIGS. 8A-D are schematic illustrations of an additional technique for treating a heart of a patient, in accordance with respective applications of the present invention;

[0124] FIGS. 9A-B are schematic illustrations of yet another technique for treating a heart of a patient, in accordance with respective applications of the present invention; and

[0125] FIGS. 10A-D are schematic illustrations of a further technique for treating a heart of a patient, in accordance with respective applications of the present invention.

DETAILED DESCRIPTION OF APPLICATIONS

[0126] FIGS. 1A-E are schematic illustrations of a technique for treating a heart 10 of a patient, in accordance with an application of the present invention. FIGS. 2A-D are schematic illustrations of another technique for treating a heart 10 of a patient, in accordance with an application of the present invention. For some applications, the techniques of FIGS. 1A-E and 2A-D are used to treat a tricuspid valve 20, such as by reducing tricuspid valve regurgitation.

[0127] As shown in FIGS. 1A-C and 2A, during a first stage of an implantation procedure, a first tissue anchor 30 is implanted in cardiac tissue of the patient, and a second tissue anchor 40 is implanted in the patient, either before or after implanting first tissue anchor 30, such that first and second tissue anchors 30 and 40 are coupled together by one or more tethers 32. For example, first tissue anchor 30 may be implanted in the vicinity of tricuspid valve 20 (as shown), e.g., on or near the annulus, and/or second tissue anchor 40 may be implanted in a superior vena cava (SVC) 42, an inferior vena cava (IVC) 44 (as shown), or a coronary sinus 46. Typically, first and second tissue anchors 30 and 40 are implanted in a transcatheter procedure (typically endovascularly, such as percutaneously), via one or more catheters 48, such as described in the applications incorporated hereinbelow by reference. Optionally, the one or more tethers 32 comprise two tethers 32 that are coupled together in situ during the first stage of the implantation procedure, such as using techniques described in one or more of the applications incorporated by reference hereinbelow. For some applications, first tissue anchor 30 comprises a helical tissue-anchoring element, or one of the anchors described in PCT Publications WO 2016/087934 and/or WO 2016/18939, which are incorporated herein by reference.

[0128] For some applications, at this first stage of the implantation procedure, the one or more tethers 32 are slack, i.e., do not apply tension between first and second tissue anchors 30 and 40.

[0129] As shown in FIGS. 1D-E and 2B-D, thereafter, during a second stage of the implantation procedure, typically after allowing at least 24 hours (e.g., at least one week, such as at least one month) for tissue growth (e.g., fibrous and/or endothelial tissue growth) on first tissue anchor 30 to strengthen anchoring of first tissue anchor 30 in the cardiac tissue, tension is applied between first and second tissue anchors 30 and 40 using at least a longitudinal portion of the one or more tethers 32. For some applications, the tension is applied within two months after implanting first tissue anchor 30. Typically, application of the tension remodels tricuspid valve 20, by drawing two or three of the leaflets together to enhance coaptation.

[0130] For some applications, such as shown in FIGS. 1A-E, the one or more tethers 32 are one or more first tethers 32, and applying the tension comprises (a) coupling a second tether 50 to a coupling site 52 along the one or more first tethers 32, and (b) applying the tension between the first and the second tissue anchors 30 and 40 using at least a longitudinal portion 54 (labeled in FIG. 1D) of the one or more first tethers 32 and second tether 50. Typically, longitudinal portion 54 extends from coupling site 52 to first tissue anchor 30.

[0131] For some applications, coupling second tether 50 to coupling site 52 comprises coupling, to coupling site 52, a coupling element 56 that is attached to second tether 50. For example, coupling element 56 may comprise a hook, as shown in FIGS. 1D-E.

[0132] Typically, applying the tension comprises coupling second tether 50 to second tissue anchor 40. For some applications, as shown, second tissue anchor 40 comprises a stent 58 that comprises a plurality of struts 60, and coupling second tether 50 to second tissue anchor 40 comprises coupling, to one or more of struts 60, a coupling element 62 that is attached to second tether 50. For some applications, coupling element 62 is shaped so as to define an opening 64, e.g., exactly one opening 64 or a plurality of openings 64, arranged, for example, axially along coupling element 62. Optionally, opening 64 is defined by a loop of coupling element 62. Providing a plurality of openings 64 provides redundancy; in case one of the openings does not catch on stent 58, another of the openings may catch (or both may catch, as shown in the figures). Optionally, coupling element 62 comprises one or more loops that are shaped so as to define the one or more openings 64, respectively.

[0133] For some applications, at least one of struts 60 is oriented axially (i.e., along the axis of the stent) as a backbone 70 (which may be thicker, wider, and/or stronger than other struts 60 and/or other axially-oriented struts 60). Coupling element 62 is coupled to backbone 70. In one configuration, backbone 70 is shaped so as to define one or more hooks 72 (e.g., exactly one hook 72, or two or more hooks 72), and coupling element 62 is coupled to one or more of hooks 72. For example, coupling element 62 may be shaped so as to define one or more openings 64, as described above. Providing a plurality of hooks 72 provides redundancy, as discussed above regarding openings 64.

[0134] Alternatively, for some applications, coupling element 62 comprises one or more hooks, which are hooked onto one or more of struts 60, such as backbone 70. For example, coupling element 62 may comprise one of coupling elements 96A, 96B, 96C, and 96D, described hereinbelow with reference to FIGS. 3A-D.

[0135] Reference is made to FIG. 1E. For some applications, a system 78 for treating a heart of a patient is provided. System 78 comprises first and second tissue anchors 30 and 40, and the one or more first tethers 32 that couple together first and second tissue anchors 30 and 40. System 78 further comprises second tether 50, which is configured to be coupled to coupling site 52 along the one or more first tethers 32, so as to apply tension between first and second tissue anchors 30 and 40 using (a) second tether 50 and (b) longitudinal portion 54 of the one or more first tethers 32. (Longitudinal portion 54 typically extends from coupling site 52 to first tissue anchor 30.) For some applications, system 78 further comprises coupling element 56 that is attached to second tether 50 and is configured to be coupled to coupling site 52 along the one or more first tethers 32. System 78 may alternatively or additionally comprise any of the other elements and/or features described hereinabove with reference to FIGS. 1A-E.

[0136] For some applications, such as shown in FIGS. 2A-D, a longitudinal portion 80 of the one or more tethers 32 passes through one or more openings 82 of a locking frame 84 so as to form a tether loop 86. As shown in FIGS. 2B-D, the tension is applied by enlarging tether loop 86 by pulling on tether loop 86. For example, a hooking element 88 may be introduced, for example, through a catheter 48, and used to temporarily snag tether loop 86 and pull on the tether loop. (The catheter may be introduced through the same vena cava as during the first stage of the implantation procedure, or through the other vena cava.) A distal end 90 of catheter 48 may be held against locking frame 84 to provide a counterforce for pulling on the tether loop. For some applications, openings 82 are configured to provide sufficient friction to prevent tether loop 86 from contracting when ordinary tensions are applied to the one or more tethers 32. For some applications, such as shown in FIGS. 2A-D, the one or more openings 82 are two openings 82, and longitudinal portion 80 of the one or more tethers 32 passes through the two openings 82.

[0137] Reference is made to FIG. 2D. For some applications, a system 94 for treating a heart of a patient is provided. System 94 comprises first and second tissue anchors 30 and 40, and the one or more tethers 32 that couple together first and second tissue anchors 30 and 40. Longitudinal portion 80 of the one or more tethers 32 passes through the one or more openings 82 of locking frame 84 so as to form tether loop 86, such that enlargement of tether loop 86 by pulling on tether loop 86 applies tension between first and the second tissue anchors 30 and 40 using at least a longitudinal portion of the one or more tethers 32. System 94 may alternatively or additionally comprise any of the other elements and/or features described hereinabove with reference to FIGS. 2A-D.

[0138] Reference is again made to FIGS. 1A-E and is additionally made to FIGS. 3A-D, which are schematic illustrations of coupling elements 96A, 96B, 96C, and 96D, respectively, in accordance with respective applications of the present invention. For some applications, coupling element 56, described hereinabove with reference to FIGS. 1A-E, comprises one of coupling elements 96A, 96B, 96C, and 96D. Alternatively or additionally, for some applications in which coupling element 62 comprises one or more hooks, as described hereinabove with reference to FIGS. 1A-E, coupling element 62 comprises one of coupling elements 96A, 96B, 96C, and 96D.

[0139] Reference is now made to FIGS. 4A-D, FIGS. 5A-D, FIGS. 6A-B, FIGS. 7A-D, FIGS. 8A-D, and FIGS. 9A-B, which are schematic illustrations of respective techniques for treating heart 10 of a patient, in accordance with respective applications of the present invention. For some applications, these techniques are used to treat tricuspid valve 20, such as by reducing tricuspid valve regurgitation.

[0140] As shown in FIGS. 4A, 5A, 7A, and 8A, during a first stage of an implantation procedure, a first tissue anchor 130 is implanted in cardiac tissue of the patient. For example, first tissue anchor 130 may be implanted in the vicinity of tricuspid valve 20 (as shown), e.g., on or near the annulus. Typically, first tissue anchor 130 is implanted in a transcatheter procedure (typically endovascularly, such as percutaneously), via one or more catheters 48, such as described in the applications incorporated hereinbelow by reference. For some applications, first tissue anchor 130 comprises a helical tissue-anchoring element, or one of the anchors described in PCT Publications WO 2016/087934 and/or WO 2016/18939, which are incorporated herein by reference.

[0141] Upon completion of the first stage of the implantation procedure, first tissue anchor 130 has no beneficial effect by itself on the heart. For example, first tissue anchor 130 does not reshape the heart valve or reduce valve regurgitation by itself.

[0142] As shown in FIGS. 4B-D, 5B-D, 7B-D, and 8B-D, thereafter, during a second stage of the implantation procedure, typically after allowing at least 24 hours (e.g., at least one week, such as at least one month) for tissue growth (e.g., fibrous and/or endothelial tissue growth) on first tissue anchor 130 to strengthen anchoring of first tissue anchor 130 in the cardiac tissue: [0143] a second tissue anchor 140 is implanted in the patient; [0144] first and second tissue anchors 130 and 140 are coupled together using one or more tethers 132, as shown in FIGS. 4B, 5B-C, 6A-B, 7B-C, 9A-B, and 8B-C; and [0145] tension is applied between first and second tissue anchors 130 and 140 using the one or more tethers 132, as shown in FIGS. 4C-D, 5D, 7D, and 8D.

[0146] First and second tissue anchors 130 and 140 may be coupled together either after or before implanting second tissue anchor 140. For some applications, second tissue anchor 140 is implanted in superior vena cava (SVC) 42, inferior vena cava (IVC) 44 (as shown), or coronary sinus 46. Typically, second tissue anchor 140 is implanted in a transcatheter procedure (typically endovascularly, such as percutaneously), via one or more catheters 48, such as described in the applications incorporated hereinbelow by reference. For some applications, second tissue anchor 140 is implanted within two months after implanting first tissue anchor 130. (The catheter used during the second stage of the implantation procedure may be introduced through the same vena cava as during the first stage of the implantation procedure, or through the other vena cava.)

[0147] For some applications, the one or more tethers 132 are fixed to second tissue anchor 140 before second tissue anchor 140 is introduced into the patient's body, while for other applications, the one or more tethers 132 are coupled to second tissue anchor 140 during the second stage of the implantation procedure, such as using techniques described hereinabove with reference to FIGS. 1A-E, 2A-D, and/or 3A-D. For some applications, second tissue anchor 140 comprises a stent 158. Stent 158 may implement any of the features of stent 58, described hereinabove with reference to FIGS. 1A-E and/or 2A-D.

[0148] Optionally, the one or more tethers 32 comprise two tethers 32 that are coupled together in situ during the second stage of the implantation procedure, such as using techniques described in one or more of the applications incorporated by reference hereinbelow.

[0149] For some applications, as shown in FIGS. 4B-D, 5B-D, 6A-B, 7B-D, 9A-B, and 8B-D, first tissue anchor 130 comprises a tissue-anchoring element 142 and a first coupling element 144. The one or more tethers 132 are attached to second tissue anchor 140 and comprise a second coupling element 146. First and second tissue anchors 130 and 140 are coupled together using the one or more tethers 132 by coupling second coupling element 146 to first coupling element 144. Optionally, first coupling element 144 is coated with a tissue-growth-inhibiting coating, e.g., silicone, and/or tissue-anchoring element 142 is coated with a tissue-growth-enhancing coating.

[0150] Reference is made to FIG. 4A-D. For some applications, second coupling element 146 comprises a loop 160, and first and second tissue anchors 130 and 140 are coupled together by coupling loop 160 to first coupling element 144. For example, first coupling element 144 may comprise a hook 162, to which loop 160 is coupled. Hook 162 may have various shapes, such as a bowl (as shown), a disc, a hook similar to hook 72 (shown in FIG. 1D), or coupling elements 96A, 96B, 96C, and 96D (shown in FIGS. 3A-D, respectively).

[0151] Reference is made to FIG. 4D. For some applications, a system 168 for treating a heart of a patient is provided. System 168 comprises: [0152] first tissue anchor 130, which is configured to be implanted in cardiac tissue of the patient, and which comprises tissue-anchoring element 142 and first coupling element 144 that comprises hook 162, [0153] second tissue anchor 140, which is configured to be implanted in the patient, and [0154] the one or more tethers 132, which are attached to second tissue anchor 140 and comprise second coupling element 146, which comprises loop 160, and which is configured to be coupled to first coupling element 144 by looping loop 160 onto hook 162.
System 168 may alternatively or additionally comprise any of the other elements and/or features described hereinabove with reference to FIGS. 4A-D.

[0155] Reference is now made to FIGS. 5A-D and 6A-B. For some applications, first coupling element 144 comprises a loop 164, and second coupling element 146 comprises a hook 166. First and second tissue anchors 130 and 140 are coupled together by hooking hook 166 onto loop 164.

[0156] Reference is made to FIGS. 5D and 6A-B. For some applications, a system 169 for treating a heart of a patient is provided. System 169 comprises: [0157] first tissue anchor 130, which is configured to be implanted in cardiac tissue of the patient, and which comprises tissue-anchoring element 142 and first coupling element 144 that comprises loop 164, [0158] second tissue anchor 140, which is configured to be implanted in the patient, and [0159] the one or more tethers 132, which are attached to second tissue anchor 140 and comprise second coupling element 146, which comprises hook 166, and which is configured to be coupled to first coupling element 144 by hooking hook 166 onto loop 164.

[0160] System 169 may alternatively or additionally comprise any of the other elements and/or features described hereinabove with reference to FIGS. 5A-D and/or 6A-B.

[0161] Reference is now made to FIGS. 7A-D and 8A-D. For some applications, first coupling element 144 comprises a ball 170, and second coupling element 146 comprises a socket 172. First and second tissue anchors 130 and 140 are coupled together by coupling socket 172 to ball 170. Optionally, ball 170 is connected to a head 174 of first tissue anchor 130 by a rod 176.

[0162] For some applications, such as shown in FIGS. 8A-D, coupling socket 172 to ball 170 comprises transitioning socket 172 from an open, unlocked state, such as shown in FIG. 8B, to a closed, locked state around ball 170, such as shown in FIGS. 8C-D. For example, socket 172 may comprise two gripping elements 178 (e.g., which are generally semispherical), which are at least partially separate from each other in the open, unlocked state and brought toward each other in the closed, locked state.

[0163] Reference is made to FIGS. 7D and 8D. For some applications, a system 180 for treating a heart of a patient is provided. System 180 comprises: [0164] first tissue anchor 130, which is configured to be implanted in cardiac tissue of the patient, and which comprises tissue-anchoring element 142 and first coupling element 144 that comprises ball 170, [0165] second tissue anchor 140, which is configured to be implanted in the patient, and [0166] the one or more tethers 132, which are attached to second tissue anchor 140 and comprise second coupling element 146, which comprises socket 172, and which is configured to be coupled to first coupling element 144 by coupling socket 172 to ball 170.
System 180 may alternatively or additionally comprise any of the other elements and/or features described hereinabove with reference to FIGS. 7A-D and 8A-D.

[0167] Reference is made to FIGS. 9A-B. For some applications, first coupling element 144 comprises socket 172, and second coupling element 146 comprises ball 170. First and second tissue anchors 130 and 140 are coupled together by coupling ball 170 to socket 172.

[0168] Reference is still made to FIGS. 9A-B. For some applications, a system 190 for treating a heart of a patient is provided. System 180 comprises: [0169] first tissue anchor 130, which is configured to be implanted in cardiac tissue of the patient, and which comprises tissue-anchoring element 142 and first coupling element 144 that comprises socket 172, [0170] second tissue anchor 140, which is configured to be implanted in the patient, and [0171] the one or more tethers 132, which are attached to second tissue anchor 140 and comprise second coupling element 146, which comprises ball 170, and which is configured to be coupled to first coupling element 144 by coupling ball 170 to socket 172.
System 190 may alternatively or additionally comprise any of the other elements and/or features described hereinabove with reference to FIGS. 9A-B.

[0172] Reference is now made to FIGS. 10A-D, which are schematic illustrations of a technique for treating heart 10 of a patient, in accordance with an application of the present invention. For some applications, this technique is used to treat tricuspid valve 20, such as by reducing tricuspid valve regurgitation. The technique of FIGS. 10A-D may be practiced in combination with any of the features described hereinabove with reference to FIGS. 4A-D, 5A-D, 6A-B, 7A-D, 8A-D, and/or 9A-B, mutatis mutandis. In this configuration, the one or more tethers 132 are one or more first tethers 132.

[0173] In addition to implanting first tissue anchor 130, such as described hereinabove with reference to FIGS. 4A-D, 5A-D, 6A-B, 7A-D, 8A-D, and 9A-B, and shown in FIG. 10A, during the first stage of the implantation procedure, typically within three hours of implanting first tissue anchor 130, a third tissue anchor 210 is implanted in cardiac tissue of the patient, such that first and third tissue anchors 130 and 210 are coupled together by one or more second tethers 212 (e.g., exactly one second tether 212), as shown in FIGS. 8B-C. For example, third tissue anchor 210 may be implanted in the vicinity of tricuspid valve 20 (as shown), e.g., on or near the annulus. Optionally, the one or more second tethers 212 comprise two second tethers 212 that are coupled together in situ during the first stage of the implantation procedure, such as using techniques described in one or more of the applications incorporated by reference hereinbelow. (The catheter used during the second stage of the implantation procedure may be introduced through the same vena cava as during the first stage of the implantation procedure, or through the other vena cava.)

[0174] First and second tissue anchors 130 and 140 are coupled together by coupling first, second, and third tissue anchors 130, 140, and 210 together using the one or more first tethers 132 and the one or more second tethers 212. The tension is applied between first and second tissue anchors 130 and 140 by applying the tension between first, second, and third tissue anchors 130, 140, and 210 using the one or more first tethers 132 and the one or more second tethers 212.

[0175] For some applications, the one or more first tethers 132 are attached to second tissue anchor 140 (typically before introducing second tissue anchor 140 into the patient's body) and comprise a coupling element 146. First, second, and third tissue anchors 130, 140, and 210 are coupled together by coupling coupling element 146 to the one or more second tethers 212. For some applications, coupling element 146 comprises a hook 214, and coupling element 146 is coupled to the one or more second tethers 212 by hooking hook 214 onto the one or more second tethers 212. Optionally, coupling element 146 may comprise one of coupling elements 96A, 96B, 96C, and 96D, described hereinabove with reference to FIGS. 3A-D.

[0176] Reference is made to FIG. 10D. For some applications, a system 220 for treating a heart of a patient is provided. System 220 comprises: [0177] first and third tissue anchors 130 and 210 configured to be implanted in cardiac tissue of the patient, [0178] second tissue anchor 140 configured to be implanted in the patient, [0179] the one or more first tethers 132, which are attached to second tissue anchor 140 and comprise coupling element 146, and [0180] the one or more second tethers 212 that couple together first and third tissue anchors 130 and 210.
Coupling element 146 is configured to be coupled to the one or more second tethers 212, to facilitate applying tension between first, second, and third tissue anchors 130, 140, and 210 using the one or more first tethers 132 and the one or more second tethers 212. System 220 may alternatively or additionally comprise any of the other elements and/or features described hereinabove with reference to FIGS. 10A-D, and/or with reference to FIGS. 4A-D, 5A-D, 6A-B, 7A-D, 8A-D, and/or 9A-B.

[0181] For some applications, fibrous glue is applied to the tissue-coupling elements of the tissue anchors described herein to help secure the anchors in place and minimize detachment. Optionally, tissue-growth-enhancing coating is also applied to the tissue-coupling elements, as described hereinabove.

[0182] The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein: [0183] U.S. Pat. No. 8,475,525 to Maisano et al.; [0184] U.S. Pat. No. 8,961,596 to Maisano et al.; [0185] U.S. Pat. No. 8,961,594 to Maisano et al.; [0186] PCT Publication WO 2011/089601; [0187] U.S. Pat. No. 9,241,702 to Maisano et al.; [0188] PCT Publication WO 2013/011502; [0189] U.S. Provisional Application 61/750,427, filed Jan. 9, 2013; [0190] U.S. Provisional Application 61/783,224, filed Mar. 14, 2013; [0191] PCT Publication WO 2013/179295; [0192] U.S. Provisional Application 61/897,491, filed Oct. 30, 2013; [0193] U.S. Provisional Application 61/897,509, filed Oct. 30, 2013; [0194] U.S. Pat. No. 9,307,980 to Gilmore et al.; [0195] PCT Publication WO 2014/108903; [0196] PCT Publication WO 2014/141239; [0197] U.S. Provisional Application 62/014,397, filed Jun. 19, 2014; [0198] PCT Publication WO 2015/063580; [0199] US Patent Application Publication 2015/0119936; [0200] U.S. Provisional Application 62/086,269, filed Dec. 2, 2014; [0201] U.S. Provisional Application 62/131,636, filed Mar. 11, 2015; [0202] U.S. Provisional Application 62/167,660, filed May 28, 2015; [0203] PCT Publication WO 2015/193728; [0204] PCT Publication WO 2016/087934; [0205] US Patent Application Publication 2016/0242762; [0206] PCT Publication WO 2016/189391; [0207] US Patent Application Publication 2016/0262741; and [0208] U.S. Provisional Application 62/376,685, filed Aug. 18, 2016.

[0209] It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.